SEEL

Seelos Therapeutics, Inc. Common Stock
SEEL

Overview Fund Activity
Delisted

SEEL was delisted on the 15th of October, 2024.

Back to rankings

24 hedge funds and large institutions have $5.86M invested in Seelos Therapeutics, Inc. Common Stock in 2019 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 7 increasing their positions, 4 reducing their positions, and 4 closing their positions.

Holders
24
Holders Change
+4
Holders Change %
+20%
% of All Funds
0.52%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.02%
New
8
Increased
7
Reduced
4
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
UIC
1
Uniplan Investment Counsel
Wisconsin
$1.52M
2
Renaissance Technologies
2
Renaissance Technologies
New York
$2.04M
3
PSC
3
Piper Sandler & Co
Minnesota
$361K
4
Vanguard Group
4
Vanguard Group
Pennsylvania
$524K
5
Geode Capital Management
5
Geode Capital Management
Massachusetts
$336K

Top Sellers

1
Millennium Management
1
Millennium Management
New York
$0
2
Jane Street
2
Jane Street
New York
$0
3
OAM
3
Oxford Asset Management
United Kingdom
$0
4
PAM
4
Panagora Asset Management
Massachusetts
$3K
5
FDCDDQ
5
Federation des caisses Desjardins du Quebec
Quebec, Canada
$0
Name Market Value Shares Shares
Change 		Shares
Change %
Bank of America
26
Bank of America
North Carolina
$0 1 – –
HI
27
Hudock Inc
Pennsylvania
$0 1 – –
CFGS
28
Concourse Financial Group Securities
Alabama
– – – –
Deutsche Bank
29
Deutsche Bank
Germany
$0 100 +100 New
1
2